Research led by Jane Harding (New Zealand & Brasenose 1978) about oral gel treatment for babies with low blood sugar gets $1.2 million in funding

"An oral dextrose gel treatment given to newborn babies at risk of potentially fatal low blood sugar levels will now be tested in a randomised trial after its lead researcher received nearly $1.2 million in funding from the Health Research Council of New Zealand (HRC).

Hypoglycaemia (low blood sugar) affects up to 15 per cent of babies, and its incidence is increasing as risk factors such as maternal diabetes and premature births become more common. With her HRC funding, Professor Jane Harding from The University of Auckland will lead a project to test, for the first time, whether oral dextrose gel applied shortly after birth - a simple, cheap and painless intervention - can prevent low blood sugar." Read more at Voxy.